Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 75

The DOI matches its Crossref record.

The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self‐reported well‐being: A randomized double‐blind controlled trial

Masoodi, Mohsen, Mahdiabadi, Mohammad Ali, Mokhtare, Marjan, Agah, Sharam, Kashani, Amir Hossein Faghihi, Rezadoost, Amir Mansoor, Sabzikarian, Mohammad, Talebi, Atefeh, Sahebkar, Amirhossein·2018·Journal of Cellular Biochemistry
DOI 10.1002/jcb.27273
Open this paper in CoChat — free account

Abstract

Background: Curcuminoids are polyphenols with documented anti‐inflammatory activity and has been shown to improve the symptoms of several inflammatory diseases. We aimed to evaluate the effectiveness of a nanoformulation of curcuminoids in the treatment of ulcerative colitis. Methods: This randomized double‐blinded controlled trial was conducted on 56 patients aged 18 years or older with the final diagnosis of mild to moderate ulcerative colitis according to the Simple Clinical Colitis Activity Index (SCCAI). The patients were randomly assigned (using a computerized random sampling table) to receive curcuminoids nanomicelles (80 mg, three times daily, orally) plus mesalamine (3 g/24 hours, orally) as the treatment group and placebo plus mesalamine (3 g/24 hours, orally) as the control group for a period of four weeks. The severity of disease was assessed at baseline and at the end of the second and fourth weeks of the treatment according to the SCCAI. Results: The score for urgency of defecation reduced significantly more in case group as compared with control group at four weeks after beginning the treatment. The patients in case group experienced better general condition than the control ones after 4 weeks of treatment. Overall, the mean SCCAI score was significantly lower in the patients received curcuminoids nanomicelles plus mesalamine as compared with the group received placebo plus mesalamine at fourth week after the treatment (1.71 ± 1.84 vs 2.68 ± 2.09, p = 0.050). Conclusion: Adding curcuminoids nanomicelles to routine treatment of patients with ulcerative colitis is associated with a significant improvement of symptoms, including reduced frequency of urgent defecation, improved patients’ self‐reported well‐being and reduced clinical activity of ulcerative colitis. ClinicalTrials. “IRCT2017052634142N1”.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcb.27273

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 34

  1. 10.1136/bmj.320.7242.1119 · DOI
  2. 10.1016/S0140-6736(16)32126-2 · DOI
  3. 10.3748/wjg.v20.i28.9458 · DOI
  4. MalekzadehR MirmadjlesiH VarshoesazJ AgahS TavakoliHRising the incidence of crohn's disease in iran during last decade(1989–1999). Gastroenterology 118:A1356. · DOI
  5. Masoodi M, 2012, Estimation of ulcerative colitis incidence in Hormozgan Province, Southern Iran, Govaresh, 16, 265
  6. Ye Y, 2015, The epidemiology and risk factors of inflammatory bowel disease, Int J Clin Exp Med, 8, 22529
  7. Meier J, 2011, Current treatment of ulcerative colitis, World J Gastroenterol, 17, 3204
  8. 10.1007/s12328-016-0686-z · DOI
  9. 10.1097/FJC.0000000000000406 · DOI
  10. 10.3109/19390211.2014.952865 · DOI
  11. 10.1055/s‐0044‐101752 · DOI
  12. 10.1002/ptr.5659 · DOI
  13. 2016, Curcumin as a MicroRNA regulator in cancer: A review reviews of physiology, Biochemistry and Pharmacology, 171, 1
  14. 10.1016/j.nut.2016.04.007 · DOI
  15. 10.5114/aoms.2017.69326 · DOI · Paper page
  16. 10.1016/j.clnu.2014.12.019 · DOI
  17. 10.1016/j.phrs.2016.03.026 · DOI
  18. 10.3109/19390211.2015.1008611 · DOI
  19. 10.1016/j.jff.2015.01.005 · DOI
  20. 10.1002/ijc.30224 · DOI
  21. 10.1016/j.phymed.2009.05.020 · DOI
  22. 10.1007/978-0-387-46401-5_3 · DOI
  23. 10.1007/s00018-008-7452-4 · DOI
  24. 10.1016/j.bmcl.2015.04.077 · DOI
  25. 10.1016/j.drudis.2016.03.007 · DOI
  26. 10.1016/j.cgh.2015.02.019 · DOI · Paper page
  27. 10.1016/j.hermed.2017.05.002 · DOI
  28. 10.1016/j.cgh.2006.08.008 · DOI · Paper page
  29. 10.1007/s10620-005-3032-8 · DOI
  30. 10.4292/wjgpt.v8.i2.147 · DOI · Paper page
  31. 10.4143/crt.2014.46.1.2 · DOI
  32. 10.1248/bpb.34.660 · DOI · Paper page
  33. 10.1158/1940-6207.CAPR-10-0006 · DOI · Paper page
  34. 10.1016/j.drudis.2011.09.009 · DOI

Cited by

See all 75

Metadata

Authors
Masoodi, M., Mahdiabadi, M. A., Mokhtare, M., Agah, S., Kashani, A. H. F., Rezadoost, A. M., Sabzikarian, M., Talebi, A., & Sahebkar, A.
Affiliations
  • Colorectal Research Center Iran University of Medical Sciences Tehran Iran
  • Neurogenic Inflammation Research Center Mashhad University of Medical Sciences Mashhad Iran
ORCID
Sahebkar, Amirhossein
Venue
Journal of Cellular Biochemistry
Publisher
Wiley
Published
2018-08-21
Volume
119
Issue
11
Pages
9552-9559
ISSN
  • 0730-2312
  • 1097-4644
DOI
10.1002/jcb.27273
Cited by
75
References
0
Language
en
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Funders
Iran University of Medical Sciences (29694)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self‐reported well‐being: A randomized double‐blind controlled trial. https://app.cochat.ai/papers/10.1002/jcb.27273
The paper
Masoodi, M., Mahdiabadi, M. A., Mokhtare, M., Agah, S., Kashani, A. H. F., Rezadoost, A. M., Sabzikarian, M., Talebi, A., & Sahebkar, A. (2018). The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self‐reported well‐being: A randomized double‐blind controlled trial. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.27273

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.